ScholarIQanswers from OpenAlex & ORCID
R. D’Incà
ResearcherPublications, citations & collaboration network
R. D’Incà is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does R. D’Incà have?
ScholarIQindexed works
R. D’Incà has 574 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does R. D’Incà have?
ScholarIQcitation count
R. D’Incà has 16,170 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of R. D’Incà?
ScholarIQh-index
R. D’Incà has an h-index of 65 in OpenAlex.
What is the i10-index of R. D’Incà?
ScholarIQi10-index
R. D’Incà has an i10-index of 205 in OpenAlex.
What is the ORCID of R. D’Incà?
ScholarIQorcid
The ORCID for R. D’Incà is on the source record.
What is the OpenAlex record for R. D’Incà?
ScholarIQopenalex
The OpenAlex for R. D’Incà is on the source record.
What are the most-cited papers on R. D’Incà?
ScholarIQmost cited works
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
Mario Cottone, Anna Kohn, Marco Daperno, Alessandro Armuzzi, Luisa Guidi, R. D’Incà, Fabrizio Bossa, Erika Angelucci, Livia Biancone, Paolo Gionchetti, Sandro Ardizzone, Claudio Papi, Walter Fries, Silvio Danese, Gabriele Riegler, Maria Cappello, Fabiana Castiglione, Vito Annese, Ambrogio Orlando
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆
Ambrogio Orlando, Alessandro Armuzzi, Claudio Papi, Vito Annese, Sandro Ardizzone, Livia Biancone, Aurora Bortoli, Fabiana Castiglione, R. D’Incà, Paolo Gionchetti